Firebrick Pharma Limited (ASX:FRE)
Australia · Delayed Price · Currency is AUD 0.0650
0.00 (0.00%)
Feb 10, 2026, 1:01 PM AEST
Firebrick Pharma Market Cap
Firebrick Pharma has a market cap or net worth of 16.27 million as of February 10, 2026. Its market cap has increased by 31.28% in one year.
Market Cap
16.27M
Enterprise Value
15.29M
Revenue
515.51K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
Market Cap Chart
Since January 28, 2022, Firebrick Pharma's market cap has decreased from 89.49M to 16.27M, a decrease of -81.81%. That is a compound annual growth rate of -34.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 16.27M | 22.64% |
| Dec 30, 2025 | 13.27M | 1.87% |
| Dec 31, 2024 | 13.03M | 46.33% |
| Dec 29, 2023 | 8.90M | -77.12% |
| Dec 29, 2022 | 38.92M | -56.51% |
| Jan 28, 2022 | 89.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 82.62B |
| Sigma Healthcare | 35.54B |
| Pro Medicus | 17.52B |
| Cochlear | 16.80B |
| Memphasys | 18.81M |
| Patrys | 18.74M |
| Neurotech International | 17.50M |
| OncoSil Medical | 17.00M |